Dane Chetkovich Archive

July 11, 2022

A speedier treatment for depression?

Vanderbilt researchers used a computer-based search to identify a compound with promise as a new, mechanistically distinct and rapid-acting therapy for major depressive disorder.

By Paul Govern
Research by Dane Chetkovich, MD, PhD, right, Ye Han, PhD, and colleagues on how antidepressants work points to possible new targets for drug development.
December 1, 2021

Study provides new insight into how antidepressant drugs work

A study by Vanderbilt researchers sheds light on how current antidepressant drugs work and suggests a new drug target in depression.

By Paul Govern
Evan Campa and Eben Cathey, along with their children, Mae and Reuben, are helping to raise funds to create an ALS research program at VUMC.
September 23, 2021

Local family shines in campaign to establish ALS research program

Evan Campa and her family are at the forefront of a campaign to establish an ALS basic science research program at Vanderbilt.

By Paul Govern
August 3, 2021

Vanderbilt University Medical Center named to U.S. News ‘Honor Roll’ of Best Hospitals

Vanderbilt University Medical Center is the only health system in the Southeast and one of only 20 hospitals nationwide to land a spot on the U.S. News & World Report’s 2021-2022 Honor Roll of America’s Best Hospitals.

By VUMC News and Communications
September 2, 2020

Telehealth team wins Elevate Team Award

“In a time of crisis and uncertainty, the Telehealth team quickly adapted to the changing guidelines and mobilized the organization to establish a robust and effective way to reach and serve our patients in their homes.”

By Jill Clendening
December 12, 2019

A new anti-seizure target?

Vanderbilt neurologists have identified a protein modification that could be targeted to reduce neuronal excitability in epilepsy.

By Leigh MacMillan